Today: 9 June 2026
Browse Category

NYSE:TMO 8 December 2025 - 9 January 2026

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher shares fell 1.7% to $606.50 Thursday, extending losses after reaching a 52-week high of $628.08 earlier in the week. Trading volume topped 3 million shares, nearly double the average. The company will present at the J.P. Morgan Healthcare Conference on Jan. 13 and report earnings Jan. 29. Investors await updates on the $8.9 billion Clario acquisition, expected to close by mid-2026.
9 January 2026
··
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

Thermo Fisher shares slipped 0.2% to $619.19 in afternoon trading Wednesday after hitting a 52-week high Tuesday. TD Cowen raised its price target to $696 and kept a “buy” rating. Investors await CEO Marc Casper’s Jan. 13 conference appearance and Jan. 29 earnings for demand signals. Director Karen S. Lynch received 53.93 phantom stock units, according to a recent Form 4 filing.
7 January 2026
··
Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus

Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus

Thermo Fisher Scientific (TMO) closed up 1.6% at $620.72, a new 52-week high, before trading flat after hours. Evercore ISI raised its price target to $650, maintaining an Outperform rating. The company announced first patient enrollment in its PPD CorEvitas Obesity Registry. CEO Marc Casper will speak at the JPMorgan Healthcare Conference on Jan. 13, with earnings due Jan. 29.
7 January 2026
·
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific shares climbed 2.4% to $606.63 after Evercore ISI raised its price target to $650 and reaffirmed an “outperform” rating. The stock traded between $590 and $608.29 on volume of 1.6 million shares. Peers Danaher, Agilent, and Illumina also advanced. Investors await Thermo Fisher’s fourth-quarter results on Jan. 29 and updates on its planned $9.4 billion Clario acquisition.
5 January 2026
···
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom

Thermo Fisher stock closes higher near 52-week high as January data, earnings loom

Thermo Fisher Scientific shares rose 2.25% to $592.51 Friday, closing about 3% below their 52-week high. The company will report Q4 and full-year results before the market opens on Jan. 29. Investors are watching for the ISM manufacturing report on Jan. 5 and U.S. jobs data on Jan. 9. Thermo Fisher’s $9.4 billion Clario deal is expected to close in early 2026.
4 January 2026
··
Thermo Fisher Scientific (TMO) Stock: Key News, Analyst Forecasts, and Catalysts to Watch Before the Market Opens on Dec. 26, 2025

Thermo Fisher Scientific (TMO) Stock: Key News, Analyst Forecasts, and Catalysts to Watch Before the Market Opens on Dec. 26, 2025

Thermo Fisher Scientific last traded near $579 in a holiday-shortened Dec. 24 session, giving the company a market cap of about $221 billion. Shares approach their 52-week high as investors watch for the closing of a planned $9.4 billion Clario acquisition, which could add $0.45 per share to adjusted earnings in its first year. U.S. markets reopen Dec. 26 after the Christmas break.
26 December 2025
·
Thermo Fisher Scientific Inc. (TMO) Stock Outlook: Latest News, Analyst Forecasts, and Key 2026 Catalysts (Dec. 25, 2025)

Thermo Fisher Scientific Inc. (TMO) Stock Outlook: Latest News, Analyst Forecasts, and Key 2026 Catalysts (Dec. 25, 2025)

Thermo Fisher Scientific shares last traded in the high-$570s on December 24, with short interest down to 5.10 million shares, or 1.35% of float. New SEC filings show Hunter Perkins Capital Management and DAVENPORT & Co LLC increased their stakes in Q3. Analyst consensus lists a “Moderate Buy” with a $616.60 average 12-month target. U.S. markets are closed for Christmas Day.
25 December 2025
·
Thermo Fisher Scientific Stock (TMO) News Today: What’s Driving Shares, Analyst Forecasts, and Key Catalysts on Dec. 19, 2025

Thermo Fisher Scientific Stock (TMO) News Today: What’s Driving Shares, Analyst Forecasts, and Key Catalysts on Dec. 19, 2025

Thermo Fisher Scientific shares rose 1.27% to $569.54 Friday after the company announced enrollment of the first patient in its PPD CorEvitas Alzheimer’s Disease Registry. The initiative aims to collect global real-world data on Alzheimer’s therapies. Thermo Fisher also opened a new collaboration center for life sciences startups in Philadelphia. Market cap stood near $218 billion.
19 December 2025
··
Thermo Fisher Scientific Stock (TMO) After Hours: Key News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 19, 2025

Thermo Fisher Scientific Stock (TMO) After Hours: Key News, Analyst Forecasts, and What to Watch Before the Market Opens on Dec. 19, 2025

Thermo Fisher Scientific (TMO) closed at $562.39 on December 18, down 0.03%, despite a broad market rally. Shares traded between $554.53 and $569.41 during the session, with about 2.24 million shares changing hands. After hours, the stock remained steady near $562.40. The company announced enrollment of the first patient in its new Alzheimer’s Disease Registry.
19 December 2025
·
Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

Thermo Fisher Scientific (TMO) Stock Today: Alzheimer’s Registry Launch, Analyst Price Targets, and 2026 Catalysts (Dec. 18, 2025)

Thermo Fisher Scientific said Thursday it enrolled the first patient in its new PPD CorEvitas Alzheimer’s Disease Registry, aimed at collecting real-world evidence on neurodegenerative care. Shares traded near $561 in the afternoon, down slightly after a 1.33% drop Wednesday. The registry will track long-term safety and effectiveness of Alzheimer’s treatments, including MRI-based monitoring of drug side effects.
18 December 2025
··
Thermo Fisher Scientific (TMO) Stock: Latest Price, Today’s Institutional Moves, and Wall Street Forecasts on Dec. 17, 2025

Thermo Fisher Scientific (TMO) Stock: Latest Price, Today’s Institutional Moves, and Wall Street Forecasts on Dec. 17, 2025

Thermo Fisher Scientific shares fell 0.8% to $565.62 Wednesday as institutional filings and analyst upgrades drove trading. Assenagon Asset Management reported a large purchase, while Union Bancaire Privée cut its stake by 30.6%. About 953,000 shares changed hands intraday. The Health Care Select Sector SPDR ETF was flat, indicating stock-specific moves.
17 December 2025
Thermo Fisher Scientific (TMO) Stock Today: KeyBanc Sets $750 Target as Moody’s Upgrades Credit – December 8, 2025

Thermo Fisher Scientific (TMO) Stock Today: KeyBanc Sets $750 Target as Moody’s Upgrades Credit – December 8, 2025

Thermo Fisher Scientific shares traded near $567 late December 8, down about 1%, despite KeyBanc upgrading the stock to “Overweight” with a $750 target and Moody’s raising its credit rating. Hedge funds and insiders trimmed positions even as the company beat earnings, raised guidance, and continued acquisitions. Market cap stands around $215 billion.
8 December 2025
·
1 2 3 4

Stock Market Today

  • Aecon Group TSX Dividend Stock Drops 20% – A Buy for Long-Term Investors
    June 8, 2026, 9:40 PM EDT. Aecon Group (TSX:ARE), a $3.1 billion market cap infrastructure firm, has dropped 20% from its 52-week high, presenting a rare buying opportunity. The company has shifted focus from cyclical civil construction to power projects, including nuclear and utilities, sectors with sustained demand. Aecon completed the Darlington Nuclear Refurbishment under budget and ahead of schedule, highlighting its strong execution. In 2025, revenue hit a record $5.4 billion, with a backlog reaching $10.9 billion in Q1 2026. The company improved margins by moving to collaborative contract models and strengthened its balance sheet by reducing debt. Aecon offers a 1.6% dividend yield with consistent growth, supported by projected free cash flow increases from $35 million in 2025 to $155 million in 2027.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Go toTop